H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Census population 542,107. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fresno clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fresno storefront.
Extracellular Matrix (ECM) Therapy in Fresno, CA for clinics & physicians. ECM therapy products provide na… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Fresno is 37.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. California is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for extracellular matrix therapy, not a walk-in clinic.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Adult obesity in Fresno is 37.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JE / Noridian Healthcare Solutions, sibling states HI, NV. California Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy extracellular matrix therapy elsewhere, use this page as a check: homologous-use language, current Noridian Healthcare Solutions article IDs, and PLACES 12.7% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 12.7% of adults — 0.7 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 21.2%. That is place-level BRFSS modeling, not a clinic census and not a Fresno trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including California. There is no Fresno storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Noridian Healthcare Solutions LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Ask for the IFU, the lot-traceability packet, and the Noridian Healthcare Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Fresno fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Fresno, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fresno is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fresno — 0.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fresno. Useful for joint-program math; still needs a diagnosis and privileging.
No Fresno storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.